MAZE
HealthcareMaze Therapeutics, Inc.
Prev Close
$51.84
Open
$51.76
High
$52.86
Low
$49.06
Volume
739.8K
Market Cap
$2.17B
P/E
—
Div Yield
—
Over the past 12 months, insider activity at Maze Therapeutics, Inc. (MAZE) has been exclusively selling, with 0 insider purchases totaling $0.00 and 10 insider sales totaling $6.01M. The most recent insider transaction was by Bernstein Harold (officer: President, R&D & CMO), who sold $1.51M worth of shares on Mar 12, 2026. Maze Therapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $2.17B.
MAZE Insider Trading Activity
MAZE Insider Buying Activity
The following table shows recent insider purchases of Maze Therapeutics, Inc. (MAZE) stock reported via SEC Form 4 filings.
No insider buying activity found for MAZE in the last 12 months.
MAZE Insider Selling Activity
The following table shows recent insider sales of Maze Therapeutics, Inc. (MAZE) stock reported via SEC Form 4 filings.